chr20-46174890-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_021248.3(CDH22):c.2103C>A(p.Asp701Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000603 in 828,990 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021248.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CDH22 | NM_021248.3 | c.2103C>A | p.Asp701Glu | missense_variant | 12/12 | ENST00000537909.4 | |
CDH22 | XM_011528994.3 | c.2103C>A | p.Asp701Glu | missense_variant | 12/12 | ||
CDH22 | XM_047440373.1 | c.1863C>A | p.Asp621Glu | missense_variant | 10/10 | ||
CDH22 | XM_024451966.2 | c.1740C>A | p.Asp580Glu | missense_variant | 12/12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CDH22 | ENST00000537909.4 | c.2103C>A | p.Asp701Glu | missense_variant | 12/12 | 2 | NM_021248.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000340 AC: 4AN: 117566Hom.: 0 Cov.: 30
GnomAD4 exome AF: 0.00000141 AC: 1AN: 711424Hom.: 0 Cov.: 32 AF XY: 0.00000287 AC XY: 1AN XY: 348546
GnomAD4 genome AF: 0.0000340 AC: 4AN: 117566Hom.: 0 Cov.: 30 AF XY: 0.0000356 AC XY: 2AN XY: 56124
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 02, 2022 | The c.2103C>A (p.D701E) alteration is located in exon 11 (coding exon 11) of the CDH22 gene. This alteration results from a C to A substitution at nucleotide position 2103, causing the aspartic acid (D) at amino acid position 701 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at